Published in Gene Therapy Weekly, January 10th, 2002
The prestigious award, which comes with $1 million dollars to help support his research for the next four years, is intended to encourage Buck's exploration of the role of the enzyme soluble adenylyl cyclase (sAC) in the aging process.
Buck, who earned his MD and PhD from the University of Tnbingen in Germany, has been a faculty member at Weill Cornell since 1992. His research into sAC has been done in collaboration with another member of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.